Published in J Consult Clin Psychol on August 01, 2000
A multisite investigation of binge eating behaviors in children and adolescents. J Consult Clin Psychol (2007) 1.72
Binge eating in overweight treatment-seeking adolescents. J Pediatr Psychol (2006) 1.64
DSM-IV psychiatric disorder comorbidity and its correlates in binge eating disorder. Int J Eat Disord (2009) 1.57
Predictors and moderators of response to cognitive behavioral therapy and medication for the treatment of binge eating disorder. J Consult Clin Psychol (2012) 1.43
Preventing excessive weight gain in adolescents: interpersonal psychotherapy for binge eating. Obesity (Silver Spring) (2007) 1.33
Examination of predictors and moderators for self-help treatments of binge-eating disorder. J Consult Clin Psychol (2008) 1.28
Psychological treatments for binge eating disorder. Curr Psychiatry Rep (2012) 1.20
The natural course of bulimia nervosa and eating disorder not otherwise specified is not influenced by personality disorders. Int J Eat Disord (2003) 1.04
Current and emerging directions in the treatment of eating disorders. Subst Abuse (2012) 0.92
Overeating among seriously overweight children seeking treatment: results of the children's eating disorder examination. Int J Eat Disord (2006) 0.92
An exploratory study of clinical measures associated with subsyndromal pathological gambling in patients with binge eating disorder. J Gambl Stud (2011) 0.87
Psychiatric disorder co-morbidity and correlates in an ethnically diverse sample of obese patients with binge eating disorder in primary care settings. Compr Psychiatry (2012) 0.86
Pathological Overeating: Emerging Evidence for a Compulsivity Construct. Neuropsychopharmacology (2016) 0.86
Clarifying boundaries of binge eating disorder and psychiatric comorbidity: a latent structure analysis. Behav Res Ther (2010) 0.85
Factors associated with binge eating disorder in pregnancy. Int J Eat Disord (2011) 0.85
Personality dimensions in bulimia nervosa, binge eating disorder, and obesity. Compr Psychiatry (2009) 0.84
Structure of diagnostic and statistical manual of mental disorders, fourth edition criteria for obsessive-compulsive personality disorder in patients with binge eating disorder. Can J Psychiatry (2008) 0.82
Comorbidity of mood and substance use disorders in patients with binge-eating disorder: Associations with personality disorder and eating disorder pathology. J Psychosom Res (2015) 0.82
A narrative review of binge eating and addictive behaviors: shared associations with seasonality and personality factors. Front Psychiatry (2013) 0.80
Psychiatric co-morbidity in women presenting across the continuum of disordered eating. Eat Behav (2014) 0.80
Binge eating disorder: the next generation of research. Int J Eat Disord (2013) 0.80
Childhood maltreatment in women with binge-eating disorder: associations with psychiatric comorbidity, psychological functioning, and eating pathology. Eat Weight Disord (2011) 0.79
Weight reduction in obese adolescents with and without binge eating. Obesity (Silver Spring) (2010) 0.78
The Role of Anxiety in Binge Eating Behavior: A Critical Examination of Theory and Empirical Literature. Health Psychol Res (2013) 0.78
Association between binge eating disorder and changes in cognitive functioning following bariatric surgery. J Psychiatr Res (2014) 0.77
Treatment-seeking patients with binge-eating disorder in the Swedish national registers: clinical course and psychiatric comorbidity. BMC Psychiatry (2016) 0.77
Changes in alcohol intake in response to transdiagnostic cognitive behaviour therapy for eating disorders. Behav Res Ther (2011) 0.76
Factor structure and clinical utility of the Beck depression inventory in patients with binge eating disorder and obesity. Gen Hosp Psychiatry (2014) 0.76
Changing the course of comorbid eating disorders and depression: what is the role of public health interventions in targeting shared risk factors? J Eat Disord (2014) 0.76
Psychiatric, behavioral, and attitudinal correlates of avoidant and obsessive-compulsive personality pathology in patients with binge-eating disorder. Compr Psychiatry (2010) 0.75
Borderline personality, self-harm behavior, and treatment outcome among eating disorders. Psychiatry (Edgmont) (2005) 0.75
A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend (2000) 4.92
Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction (1998) 2.88
Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch Gen Psychiatry (2001) 2.29
Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst (1996) 2.12
Representation of older patients in cancer treatment trials. Cancer (1994) 2.06
One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. Addiction (2000) 1.93
Oat products and lipid lowering. A meta-analysis. JAMA (1992) 1.90
The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. N Engl J Med (1995) 1.74
Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol (1986) 1.70
Retinoids in cancer therapy. J Clin Oncol (1992) 1.59
Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103. J Clin Oncol (1993) 1.44
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol (1989) 1.28
Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev (1988) 1.25
The therapy of osteogenic sarcoma: current status and thoughts for the future. J Surg Oncol (1972) 1.24
Thalamo-cortical processing of vibrissal information in the rat. I. Intracortical origins of surround but not centre-receptive fields of layer IV neurones in the rat S1 barrel field cortex. J Comp Neurol (1991) 1.21
Primary hepatocellular cancer--present results and future prospects. Int J Radiat Oncol Biol Phys (1983) 1.20
Relation of media exposure to eating disorder symptomatology: an examination of mediating mechanisms. J Abnorm Psychol (1994) 1.16
Antineoplastic activity of cannabinoids. J Natl Cancer Inst (1975) 1.14
A sibling study of sensation seeking and opiate addiction. J Nerv Ment Dis (1994) 1.13
Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy Phase 2 (CALERIE Phase 2) screening and recruitment: methods and results. Contemp Clin Trials (2012) 1.10
1991 national survey of carcinoma of the breast by the Commission on Cancer. J Am Coll Surg (1994) 1.09
Accrual to clinical trials. J Natl Cancer Inst (1988) 1.09
National Cancer Institute's evaluation of unconventional cancer treatments. J Natl Cancer Inst (1992) 1.08
Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treat Rev (1980) 1.07
Neonatal parathyroid function: role of gestational age and postnatal age. J Pediatr (1973) 1.06
Tamoxifen: trials, tribulations, and trade-offs. J Natl Cancer Inst (1994) 1.05
A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes. J Clin Oncol (1986) 1.02
Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals. JAMA (1978) 0.98
5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma. Eur J Cancer (1972) 0.97
Insurance coverage of patients with breast cancer in the 1991 commission on cancer patient care evaluation study. Ann Surg Oncol (1994) 0.96
Evolution of time coding systems. Neural Comput (1999) 0.96
Inhibition by aflatonin B-1 of hydrocortisone induction of rat liver tryptophan pyrrolase and tyrosine transaminase. Arch Biochem Biophys (1968) 0.95
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. J Clin Oncol (1991) 0.95
Metabolism, disposition and excretion of [14C]melamine in male Fischer 344 rats. Food Chem Toxicol (1983) 0.95
Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Ann Intern Med (1984) 0.93
Toxicity of methyl testosterone in the beagle dog. Toxicology (1977) 0.93
A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma. J Clin Oncol (1985) 0.92
Metabolism of benzophenone-3 in rats. Drug Metab Dispos (1993) 0.91
Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial. J Clin Oncol (1995) 0.91
Rapid gastric absorption of sodium nitrite in mice. J Pharm Sci (1972) 0.91
Pharmacokinetics of benzophenone-3 after oral exposure in male rats. J Appl Toxicol (1995) 0.90
Generalizability of the type A/type B distinction across different psychoactive substances. Am J Drug Alcohol Abuse (1996) 0.89
Relationship between acrylamide reproductive and neurotoxicity in male rats. Reprod Toxicol (2000) 0.89
Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol (1987) 0.89
Disposition of benzophenone-3 after dermal administration in male rats. Toxicol Lett (1994) 0.89
1-Aminobenzotriazole inhibits acrylamide-induced dominant lethal effects in spermatids of male mice. Mutagenesis (2000) 0.88
Estrogen receptors in male breast cancer: clinical and pathologic correlations. Cancer (1981) 0.88
Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study. Cancer Treat Rep (1980) 0.88
A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958). Cancer Treat Rev (1980) 0.87
Pharmacokinetics and metabolism of ftorafur in man. Cancer Treat Rep (1979) 0.86
Testicular cancer: role of biological tumor markers. Cancer Treat Rev (1979) 0.86
Hepatomas: hormone receptors and therapy. Am J Med (1982) 0.86
Patient accrual to clinical trials. Cancer Treat Rep (1987) 0.86
Adjuvant therapy for breast cancer patients with negative lymph nodes. NCI Monogr (1986) 0.85
Additive and synergistic inhibition of mammalian microsomal enzyme functions by piperonyl butoxide, safrole and other methylenedioxyphenyl derivatives. Experientia (1971) 0.85
Time coding in the midbrain of mormyrid electric fish. I. Physiology and anatomy of cells in the nucleus exterolateralis pars anterior. J Comp Physiol A (1998) 0.85
Neoadjuvant therapy in cancer treatment. Cancer (1993) 0.84
Clinical development of Taxol. J Natl Cancer Inst Monogr (1993) 0.84
Malignant pleural effusions. Cancer Treat Rev (1978) 0.83
Adjuvant multimodality treatment of rectal cancer. Br J Surg (1989) 0.83
Meeting highlights: a reappraisal of research results for the local treatment of early stage breast cancer. J Natl Cancer Inst (1995) 0.82
Some structural and functional consequences of hepatic adenosine triphosphate deficiency induced by intraperitoneal D-fructose administration. Lab Invest (1970) 0.82
Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma. J Clin Oncol (1986) 0.82
Surgical oncology research. A disappointing status report. Ann Surg (1988) 0.82
Induction of tunica vaginalis mesotheliomas in rats by xenobiotics. Crit Rev Toxicol (2009) 0.81
Liver nuclear RNA metabolism in rats treated with aflatoxin B1. Life Sci II (1970) 0.81
Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study. Cancer Treat Rep (1979) 0.81
Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexate. Cancer Chemother Pharmacol (1982) 0.80
Paclitaxel (Taxol) in breast cancer. Hematol Oncol Clin North Am (1994) 0.80
The clinical value of hormone receptor assays in malignant disease. Cancer Treat Rev (1978) 0.80
Differentiating agents in the treatment of human malignancies. Cancer Treat Rev (1986) 0.80
A comparison of alternate systems for diagnosing antisocial personality disorder in cocaine abusers. J Nerv Ment Dis (1993) 0.80
Therapy of hepatocellular cancer with combined intrahepatic arterial chemotherapy and whole liver irradiation. Ann Acad Med Singapore (1980) 0.80
Self-directed hostility and family functioning in normal-weight bulimics and overweight binge eaters. Addict Behav (1997) 0.79
Direct effect of the neurotoxicant acrylamide on kinesin-based microtubule motility. J Neurosci Res (1996) 0.79
Concurrent and predictive validity of antisocial personality disorder subtyping among substance abusers. J Nerv Ment Dis (1999) 0.79
Neurotoxicity of glycidamide, an acrylamide metabolite, following intraperitoneal injections in rats. J Toxicol Environ Health (1993) 0.79
Manufacturer's warning regarding unapproved uses of misoprostol. N Engl J Med (2001) 0.79
Some thoughts on the future of clinical trials in cancer. Cancer Treat Rep (1986) 0.79
New chemotherapeutic agents in non-small-cell lung cancer. Semin Oncol (1993) 0.79
Hormone receptors in renal cell carcinoma. Their utility as predictors of response to endocrine therapy. Cancer Chemother Pharmacol (1981) 0.79
A cross-over response to sequential use of sunitinib after sorafenib in a patient with metastatic renal cell carcinoma. Clin Oncol (R Coll Radiol) (2009) 0.78
Combined radiotherapy and multidrug chemotherapy for advanced head and neck cancer: results of a Radiation Therapy Oncology Group pilot study. Cancer Treat Rep (1979) 0.78
Progress against rare and not-so-rare cancers. N Engl J Med (1992) 0.78
Parathyroid function in infants of diabetic mothers. J Pediatr (1975) 0.78
How accurate are computed tomographic scans in assessment of changes in tumor size? Am J Med (1983) 0.78
Toxic neurofilamentous axonopathies and fast axonal transport. V. Reduced bidirectional vesicle transport in cultured neurons by acrylamide and glycidamide. J Toxicol Environ Health (1994) 0.78
Sequential combination of bleomycin and mitomycin in advanced cervical cancer--an American experience: a Northern California Oncology Group study. Cancer Treat Rep (1982) 0.78
Chemotherapy of disseminated gastric cancer. A joint effort of the Northern California Oncology Group and the Japanese Gastric Cancer Chemotherapy Group. Cancer (1983) 0.78
Rat two-generation reproduction and dominant lethal study of acrylamide in drinking water. Reprod Toxicol (2000) 0.78
The distribution of [14C]caprolactam in male, female and pregnant mice. Food Chem Toxicol (1984) 0.77
Trans-retinoic acid and related differentiation agents. Semin Oncol (1992) 0.77
The fluoropyrimidines: biochemical mechanisms and design of clinical trials. Cancer Chemother Pharmacol (1978) 0.77
Suppression of dimethylnitrosamine metabolism and toxicity by nitrososarcosine and other nitrosamines. Toxicol Appl Pharmacol (1976) 0.77
Types of abuse and cocaine use in pregnant women. J Subst Abuse Treat (1998) 0.77
Retinoids in the lateral eye of Limulus: evidence for a retinal photoisomerase. Vis Neurosci (1992) 0.77
Carcinogen activation by human liver enzymes in the Ames mutagenicity test. Mutat Res (1977) 0.77
Response of the pituitary and thyroid to tropic hormones in Sprague-Dawley versus Fischer 344 male rats. Toxicol Sci (1999) 0.77
Role of dimethylnitrosamine-demethylase in the metabolic activation of dimethylinitrosamine. Chem Biol Interact (1979) 0.77